These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Menopausal hormone replacement: not necessarily routine. Guinan ME J Med Assoc Ga; 1994 Apr; 83(4):205-8. PubMed ID: 8006547 [No Abstract] [Full Text] [Related]
27. [Psychosocial aspects of the climacteric]. Buddeberg C; Buddeberg-Fischer B Praxis (Bern 1994); 1995 Jun; 84(24):718-21. PubMed ID: 7792468 [TBL] [Abstract][Full Text] [Related]
28. The impact of the Women's Health Initiative study on incident clonidine use in Ontario, Canada. Austin PC; Mamdani MM; Tu K Can J Clin Pharmacol; 2004; 11(2):e191-4. PubMed ID: 15520472 [TBL] [Abstract][Full Text] [Related]
29. [Possibilities for an individualized approach to the treatment of climacteric symptoms with phytoestrogens]. Kolarov G; Nalbanski B; Kamenov Z; Orbetsova M; Georgiev S; Nikolov A; Marinov B Akush Ginekol (Sofiia); 2001; 40(4):18-21. PubMed ID: 11803864 [TBL] [Abstract][Full Text] [Related]
30. [Low-dose estrogens in the treatment of the climacteric syndrome]. Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038 [TBL] [Abstract][Full Text] [Related]
31. Double-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptoms. Alcoff JM; Campbell D; Tribble D; Oldfield B; Cruess D Clin Ther; 1981; 3(5):356-64. PubMed ID: 7471131 [TBL] [Abstract][Full Text] [Related]
32. [Is there a menopausal syndrome? Alternative therapies help]. Landgren BM; Collins A Lakartidningen; 1994 Jun; 91(23):2316-8. PubMed ID: 8057707 [No Abstract] [Full Text] [Related]
35. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy. Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528 [TBL] [Abstract][Full Text] [Related]
36. Does adding estrogen to the hormone-free days of an oral contraceptive (OC) cycle reduce menopausal symptoms in perimenopausal OC users? Bielanski TE J Fam Pract; 2001 Oct; 50(10):838. PubMed ID: 11674879 [No Abstract] [Full Text] [Related]
37. [Splenopeptides for climacteric complaints. Comparison of ovarian stimulation with transdermal estradiol substitution]. Lauritzen C; Teucher T; Schmitz H Arzneimittelforschung; 1995 Mar; 45(3):315-22. PubMed ID: 7741793 [TBL] [Abstract][Full Text] [Related]
38. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer]. Magnusson C; Weiderpass E Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082 [TBL] [Abstract][Full Text] [Related]
39. [Social medicine aspects of pre- and postmenopause]. Schmeiser-Rieder A; Concin H; Schwarz B; Kunze M Wien Med Wochenschr; 1995; 145(14):331-3. PubMed ID: 7483647 [TBL] [Abstract][Full Text] [Related]
40. Alternatives to estrogen for the treatment of hot flashes. Lucero MA; McCloskey WW Ann Pharmacother; 1997; 31(7-8):915-7. PubMed ID: 9220057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]